Biotechnology

AGC to Complete the Acquisition of MolMed on July 31, 2020

AGC Biologics adds leading-edge cell & gene therapy company in Milan, Italy SEATTLE, July 28, 2020 /PRNewswire/ -- AGC Biologics, a Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that they will acquire the majority of the share capital of Molec...

2020-07-28 10:00 3691

Geltor Raises $91.3M as Pandemic Exposes Need for Sustainable Protein Supply Chain

Biodesign Leader to Expand Its Sustainable Ingredients-as-a-Service™ Platform Globally SAN LEANDRO, California, July 28, 2020 /PRNewswire/ -- Geltor today announced the closing of a$91.3M Series B financing that will fuel the global expansion of its Ingredients-as-a-Service™ platform. The fundin...

2020-07-28 02:08 2431

Dow and Thong Guan introduces sustainable plastic stretch cling films made with renewable feedstock in Asia Pacific

SINGAPORE, July 27, 2020 /PRNewswire/ -- Dow (NYSE: DOW) and Thong Guan, one of the world's leading plastic stretch cling film producers, today introduced a new range of bio-based polyethylene (bio-PE) inAsia Pacific. This marks a milestone in the region's commercialization of a plastics offering...

2020-07-27 11:43 5435

COVID-19 Vaccines Test Safe & Effective by China & UK teams: the Lancet

BEIJING, July 24, 2020 /PRNewswire/ -- A news report by Science and Technology Daily: Good news. On July 20th, The Lancet published two papers online at the same time, revealing the results of clinical trials for two COVID-19 vaccines. From China and the United Kingdom respectively, the two stars...

2020-07-24 00:55 4274

APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer

APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology. DELHI, India, July 23, 2020 /...

2020-07-23 22:00 2886

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

World's first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings FREMONT, Calif., July 21, 2020 /PRNewswire/ -- LifeSignals Group, today announced USFDA 510(k) clearance has been received for ...

2020-07-21 19:00 4290

China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor

SHANGHAI and SAN FRANCISCO and WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB) and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for ripretinib...

2020-07-20 22:39 4712

PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit

HONG KONG, July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European In-Vitro D...

2020-07-20 09:00 4166

Bridging Study in China Completed for NASH Drug Candidate ASC40

HANGZHOU and SHAOXING, China, July 20, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that a single-dose, pharmacokinetic bridging study of non-alcoholic steatohepatitis (NASH) drug candidate ASC40 (TVB-2640) in 34 Chinese subjects has been completed and data indicate...

2020-07-20 08:30 4845

Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, July 16, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical stage biopharmaceutical company, today announced that the Company presented preclinical data from a fully human CD73 antibody (HBM1007) in an e-poster at the American...

2020-07-16 18:00 4202

Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field

TOKYO and DEVENTER, Netherlands, July 15, 2020 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., aNetherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radia...

2020-07-15 14:05 18431

Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies With Precision-Targeted T-Cell Engaging Antibodies

- Novel antibody-based cancer immunotherapies to be developed through combining Revitope's dual-antigen precision T-cell engager platform (TEAC) and Junshi Biosciences' antibodies - Revitope to design up to 5 TEAC molecules against tumor targets selected by Junshi Biosciences - For each TEAC mo...

2020-07-14 09:01 6499

Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models

Five technologies empowering preclinical disease modeling are providing preclinical research with highly accurate and precise services SANTA CLARA, California, July 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advances Facilitating Research across Preclinical Disease...

2020-07-14 01:55 1502

PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19

FLORENCE, Italy, July 13, 2020 /PRNewswire/ -- With the pandemic caused by COVID-19, the continuous need to obtain information has pushed people to rely on unreliable sources, thus fomenting thespread of fake news. For this reason Gilda D'Incerti, CEO and founder of PQE Group

2020-07-13 16:00 2664

World's First FDA IDE Coronary Patient Treated With a DEB

NYON, Switzerland, July 11, 2020 /PRNewswire/ --  MedAlliance has announced enrollment of the first patient in its study ofSELUTION SLR™ 014 DEB  for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Progr...

2020-07-11 08:00 3375

Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study

STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is an ef...

2020-07-10 13:32 1669

PolyU discovers the effect of chemical compound PTU on autophagy in zebrafish embryos, sheds light on cancer medication research

HONG KONG, July 10, 2020 /PRNewswire/ -- The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least one zeb...

2020-07-10 10:18 2791

AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program

SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)AGC Biologics is partnering with clinical-stage biotech companyMolecular Partners AG to develop a new class of custom-built protein therapeutics known as DARPin®. AGC Biologics...

2020-07-09 13:00 2824

Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China

SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...

2020-07-09 08:00 12369

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Paige leveraged the world's largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizesPaige with the...

2020-07-08 23:40 1780
1 ... 161162163164165166167 ... 177